Aripiprazole Accord

Country: European Union

Language: Maltese

Source: EMA (European Medicines Agency)

Active ingredient:

aripiprazole

Available from:

Accord Healthcare S.L.U.

ATC code:

N05AX12

INN (International Name):

aripiprazole

Therapeutic group:

Psikolettiċi

Therapeutic area:

Schizophrenia; Bipolar Disorder

Therapeutic indications:

Aripiprazole Qbil huwa indikat għat-trattament ta'l-iskizofrenija fl-adulti u fl-adoloxxenti ta'bejn il-15-il sena u anzjani. Aripiprazole Qbil huwa indikat għat-trattament ta 'episodji manijaċi serji f'Disturb Bipolari I u għall-prevenzjoni ta' episodju manijaku ġdid f'adulti li esperjenzaw episodji predominantament manijaċi u li l-episodji manijaċi rrispondew għat-trattament b'aripiprazole. Aripiprazole Qbil huwa indikat għall-kura sa 12-il ġimgħa ta 'episodji manijaċi serji f'Disturb Bipolari I fl-adolexxenti ta' minn 13-il sena u anzjani.

Product summary:

Revision: 15

Authorization status:

Awtorizzat

Authorization date:

2015-11-15

Patient Information leaflet

                                45
B. FULJETT TA’ TAGĦRIF
46
FULJETT TA’ TAGĦRIF: INFORMAZZJONI GĦALL-UTENT
ARIPIPRAZOLE ACCORD 5 MG PILLOLI
ARIPIPRAZOLE ACCORD 10 MG PILLOLI
ARIPIPRAZOLE ACCORD 15 MG PILLOLI
ARIPIPRAZOLE ACCORD 30 MG PILLOLI
aripiprazole
AQRA SEW DAN IL-FULJETT KOLLU QABEL TIBDA TIEĦU DIN IL-MEDIĊINA
PERESS LI FIH INFORMAZZJONI
IMPORTANTI GĦALIK.
•
Żomm dan il-fuljett. Jista’ jkollok bżonn terġa’ taqrah.
•
Jekk ikollok aktar mistoqsijiet, staqsi lit-tabib jew lill-ispiżjar
tiegħek.
•
Din il-mediċina ġiet mogħtija lilek biss. M’għandekx tgħaddiha
lil persuni oħra. Tista’
tagħmlilhom il-ħsara, anki jekk ikollhom l-istess sinjali ta’ mard
bħal tiegħek.
•
Jekk ikollok xi effett sekondarju kellem lit-tabib jew lill-ispiżjar
tiegħek. Dan jinkludi xi effett
sekondarju possibbli li mhuwiex elenkat f’dan il-fuljett. Ara
sezzjoni 4.
F’DAN IL-FULJETT
1.
X’inhu Aripiprazole Accord u għalxiex jintuża
2.
X’għandek tkun taf qabel ma tieħu Aripiprazole Accord
3.
Kif għandek tieħu Aripiprazole Accord
4.
Effetti sekondarji possibbli
5
Kif taħżen Aripiprazole Accord
6.
Kontenut tal-pakkett u informazzjoni oħra
1.
X’INHU ARIPIPRAZOLE ACCORD U GĦALXIEX JINTUŻA
Aripiprazole Accord fih is-sustanza attiva aripiprazole u jappartjeni
għal grupp ta’ mediċini msejħa
antipsikotiċi. Huwa jintuża
biex jiġu kkurati adulti u adolexxenti li għandhom 15-il sena jew
aktar li
jbatu minn marda kkaratterizzata minn sintomi bħalma huma smigħ,
viżta jew ħass ta’ affarijiet li
mhumiex hemm, suspetti, ħsieb ħażin, diskors li ma jinftehimx u
mġiba mħawda, u nuqqas ta’
emozzjoni. Nies li jbatu b’din il-kundizzjoni jistgħu wkoll
iħossuhom imdejqin, ħatja, anzjużi u
b’tensjoni.
Din il-mediċina tintuża biex tikkura adulti u adolexxenti li
għandhom 13-il sena jew aktar li jsofru
minn kundizzjoni b’sintomi bħalma huma li wieħed iħossu ewforiku
żżejjed, ikollu ammonti eċċessivi
ta’ enerġija, jeħtieġ ferm inqas irqad min-normal, jitkellem
malajr ħafna b’ideat li j
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                1
ANNESS I
SOMMARJU TAL-KARATTERISTIĊI TAL-PRODOTT
2
1.
ISEM IL-PRODOTT MEDIĊINALI
Aripiprazole Accord 5 mg pilloli
Aripiprazole Accord 10 mg pilloli
Aripiprazole Accord 15 mg pilloli
Aripiprazole Accord 30 mg pilloli
2.
GĦAMLA KWALITATTIVA U KWANTITATTIVA
Aripiprazole Accord 5 mg pilloli
Kull pillola għandha 5 mg ta’ aripiprazole.
Eċċipjent(i) b’effett magħruf
Kull pillola ta’ 5 mg fiha 63 mg lactose (bħala monohydrate).
Aripiprazole Accord 10 mg pilloli
Kull pillola għandha 10 mg ta’ aripiprazole.
Eċċipjent(i) b’effett magħruf
Kull pillola ta’ 10 mg fiha 59 mg lactose (bħala monohydrate).
Aripiprazole Accord 15 mg pilloli
Kull pillola għandha 15 mg ta’ aripiprazole.
Eċċipjent(i) b’effett magħruf
Kull pillola ta’ 15 mg fiha 88 mg lactose (bħala monohydrate).
Aripiprazole Accord 30 mg pilloli
Kull pillola għandha 30 mg ta’ aripiprazole.
Eċċipjent(i) b’effett magħruf
Kull pillola ta’ 30 mg fiha 177 mg lactose (bħala monohydrate).
Għal-lista kompluta ta’ eċċipjenti, ara sezzjoni 6.1.
3.
GĦAMLA FARMAĊEWTIKA
Pillola
Aripiprazole Accord 5 mg pilloli
Pilloli mhux miksija, bikonvessi, b’forma rettangolari modifikata,
b’wisa’ ta’ madwar 4.6 mm, b’tul
ta’ madwar 8.1 mm, ta’ kulur blu, b’“A5” imnaqqxa fuq naħa
minnhom u bin-naħa l-oħra sempliċi.
Aripiprazole Accord 10 mg pilloli
Pilloli mhux miksija, bikonvessi, b’forma rettangolari modifikata,
b’wisa’ ta’ madwar 4.6 mm, b’tul
3
ta’ madwar 8.1 mm, ta’ kulur roża, b’“A10” imnaqqxa fuq
naħa minnhom u bin-naħa l-oħra sempliċi.
Aripiprazole Accord 15 mg pilloli
Pilloli mhux miksija, bikonvessi, b’xifer imżerżaq, b’forma
tonda, b’dijametru ta’ madwar 7.14 mm,
ta’ kulur isfar, b’“A15” imnaqqxa fuq naħa minnhom u
bin-naħa l-oħra sempliċi.
Aripiprazole Accord 30 mg pilloli
Pilloli mhux miksija, bikonvessi, b’xifer imżerżaq, b’forma
tonda, b’dijametru ta’ madwar 9.1 mm, ta’
kulur roża, b’“A30” imnaqqxa fuq naħa minnhom u bin-naħa
l-oħra 
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 03-11-2022
Summary of Product characteristics Summary of Product characteristics Bulgarian 03-11-2022
Public Assessment Report Public Assessment Report Bulgarian 27-11-2015
Patient Information leaflet Patient Information leaflet Spanish 03-11-2022
Public Assessment Report Public Assessment Report Spanish 27-11-2015
Patient Information leaflet Patient Information leaflet Czech 03-11-2022
Public Assessment Report Public Assessment Report Czech 27-11-2015
Patient Information leaflet Patient Information leaflet Danish 03-11-2022
Public Assessment Report Public Assessment Report Danish 27-11-2015
Patient Information leaflet Patient Information leaflet German 03-11-2022
Public Assessment Report Public Assessment Report German 27-11-2015
Patient Information leaflet Patient Information leaflet Estonian 03-11-2022
Public Assessment Report Public Assessment Report Estonian 27-11-2015
Patient Information leaflet Patient Information leaflet Greek 03-11-2022
Public Assessment Report Public Assessment Report Greek 27-11-2015
Patient Information leaflet Patient Information leaflet English 03-11-2022
Public Assessment Report Public Assessment Report English 27-11-2015
Patient Information leaflet Patient Information leaflet French 03-11-2022
Public Assessment Report Public Assessment Report French 27-11-2015
Patient Information leaflet Patient Information leaflet Italian 03-11-2022
Public Assessment Report Public Assessment Report Italian 27-11-2015
Patient Information leaflet Patient Information leaflet Latvian 03-11-2022
Public Assessment Report Public Assessment Report Latvian 27-11-2015
Patient Information leaflet Patient Information leaflet Lithuanian 03-11-2022
Summary of Product characteristics Summary of Product characteristics Lithuanian 03-11-2022
Public Assessment Report Public Assessment Report Lithuanian 27-11-2015
Patient Information leaflet Patient Information leaflet Hungarian 03-11-2022
Summary of Product characteristics Summary of Product characteristics Hungarian 03-11-2022
Public Assessment Report Public Assessment Report Hungarian 27-11-2015
Patient Information leaflet Patient Information leaflet Dutch 03-11-2022
Public Assessment Report Public Assessment Report Dutch 27-11-2015
Patient Information leaflet Patient Information leaflet Polish 03-11-2022
Public Assessment Report Public Assessment Report Polish 27-11-2015
Patient Information leaflet Patient Information leaflet Portuguese 03-11-2022
Summary of Product characteristics Summary of Product characteristics Portuguese 03-11-2022
Public Assessment Report Public Assessment Report Portuguese 27-11-2015
Patient Information leaflet Patient Information leaflet Romanian 03-11-2022
Public Assessment Report Public Assessment Report Romanian 27-11-2015
Patient Information leaflet Patient Information leaflet Slovak 03-11-2022
Public Assessment Report Public Assessment Report Slovak 27-11-2015
Patient Information leaflet Patient Information leaflet Slovenian 03-11-2022
Summary of Product characteristics Summary of Product characteristics Slovenian 03-11-2022
Public Assessment Report Public Assessment Report Slovenian 27-11-2015
Patient Information leaflet Patient Information leaflet Finnish 03-11-2022
Public Assessment Report Public Assessment Report Finnish 27-11-2015
Patient Information leaflet Patient Information leaflet Swedish 03-11-2022
Public Assessment Report Public Assessment Report Swedish 27-11-2015
Patient Information leaflet Patient Information leaflet Norwegian 03-11-2022
Summary of Product characteristics Summary of Product characteristics Norwegian 03-11-2022
Patient Information leaflet Patient Information leaflet Icelandic 03-11-2022
Summary of Product characteristics Summary of Product characteristics Icelandic 03-11-2022
Patient Information leaflet Patient Information leaflet Croatian 03-11-2022
Public Assessment Report Public Assessment Report Croatian 27-11-2015

Search alerts related to this product